Resources from the same session
LBA2 - Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT) in pretreated, inoperable/metastatic HR+/HER2– breast cancer (BC): Additional safety analysis from TROPION-Breast01
Presenter: Komal Jhaveri
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session 2
Resources:
Webcast
266O - Safety of assisted reproductive techniques in young BRCA carriers with a pregnancy after breast cancer: Results from an international cohort study
Presenter: Matteo Lambertini
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
109O - Adjuvant endocrine therapy for premenopausal invasive lobular carcinoma (ILC): Results from SOFT and TEXT phase III studies
Presenter: Otto Metzger
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session 2
Resources:
Webcast